Calcitonin gene-related peptide (CGRP) is a 37-amino acid peptide that is a potent coronary vasodilator. Although CGRP is found in high concentrations around coronary arteries, its precise function in the control of coronary vasomotor tone remains unclear. We studied the distribution of specific receptors for CGRP in guinea pig and human hearts and found that the highest concentration of specific receptors for CGRP was in the major coronary arteries, which is consistent with the hypothesis that CGRP is implicated in control of coronary vasomotor tone. Areas of coronary artery with atheroma contained significantly decreased (158+±35 grains/1,000 jLm2 tissue, n=3) binding sites compared with binding sites in normal arteries (266±10 grains/1,000 ,um2 tissue, n=11; p<0.001, t test). The decrease in receptors for CGRP around atheroma may predispose these vessels to coronary spasm. (Circulation 1990;81:741-747) C alcitonin gene-related peptide (CGRP) is a 37-amino acid peptide, the existence of which was predicted by analysis of the calcitonin gene.1 CGRP has been detected in various tissues, including the thyroid gland,2 neuroendocrine cells,3 and peripheral sensory nerves, and its physiologic importance is unknown.
C alcitonin gene-related peptide (CGRP) is a 37-amino acid peptide, the existence of which was predicted by analysis of the calcitonin gene.1 CGRP has been detected in various tissues, including the thyroid gland,2 neuroendocrine cells,3 and peripheral sensory nerves, and its physiologic importance is unknown.
CGRP is an extremely potent vasodilator in animal and human vessels,4 including coronary arteries. 5 Immunohistochemical studies of animal and human tissues have shown that CGRP is localized to the nerves around the coronary arteries and arterioles.6 CGRP may be detected in the circulation in picomolar concentrations,4 and infusion of CGRP into the coronary arteries causes dilatation of large and small vessels.57 However, because CGRP almost certainly has its major effects by local release from nerves, the relevance of infusion studies may be questioned. Study of specific receptors, therefore, may provide a more accurate reflection of physiologic function.
Specific cell surface receptors for CGRP have been identified in a number of tissues by direct receptorbinding assay with [1251]-labeled CGRP.8 Because receptor-binding studies of membrane preparations do not give information about the localization of receptors, we investigated the distribution of CGRP receptors with an autoradiographic technique in human hearts removed at cardiac transplantation and in guinea pig hearts.
Methods

Tissue Preparation
Human coronary arteries and hearts were removed at cardiac transplantation. Five human hearts were studied, and all the patients were suffering from end-stage ischemic heart disease. The myocardial sections were taken from grossly noninfarcted tissue, and the arteries were a mixture of angiographically normal, stenosed, and occluded vessels. Guinea pig hearts were removed from freshly killed animals.
The tissues were snap-frozen in liquid dichlorodifluomethane (Arcton 12, ICI, Macclesfield, UK) and cooled to -196°C by liquid nitrogen. Tissue sections (8) (9) (10) ,gm) were cut on a cryostat at -28°C and thaw-mounted onto glass microscope slides coated with poly-l-lysine. The sections were then stored at -80' C , 500 KIU/ml aprotinin, and 0.5 mg/ml bacitracin. Incubation was followed by two 5-minute washes in ice-cold buffer.
Nonspecific binding was determined on adjacent sections by incubating the tissue sections in the presence of 1-,uM unlabeled CGRP. Under these conditions, the specific binding represented approximately 50% of the total binding for human and guinea pig hearts.
Autoradiography
Autoradiographs were generated by the method of Young and Kuhar.10 Slide-mounted sections were incubated as previously described, washed with icecold buffer (twice for 5 minutes each), and then rinsed in distilled-water to remove residual salts, air dried rapidly, and stored dessicated overnight. Glass coverslips that had previously been coated with stripping film (AR 10 Kodak, London, UK) were then fixed to one end of the slide with cyanoacrylate adhesive and held in contact with the sections by butterfly clips. Slides were exposed to emulsion at 40 C for 5 days. The coverslips were then partially separated from the slides, and the sections and the emulsion were developed and fixed. The sections were stained with 1% cresyl violet and examined under a microscope equipped with light-and darkfield illumination.
Grains were counted on autoradiographs by using a calibrated eyepiece and were also counted on developed photographs. The relative binding to each site was compared by counting the individual grains with an oil emulsion lens (x 1,000 magnification) in 12 separate areas of 7 x 7 gm2 from each section studied, which yielded a total grain count area of nearly 600 gm2 for each section. To minimize bias in the counting, the same squares in the graticule were assessed for each tissue, and the grains were counted by an individual who was not aware of which region was being counted. Similar results were obtained in separate tissue sections from the same and from separate guinea pigs. Grain counts in human tissue sections were made in a similar fashion.
Additional counts were made from developed photographs within a specified area, or in the case of small vessels, the total grains per vessel were counted, and the area of smooth muscle was calculated from a digitized image in the bright-field view. After correction for background counts, nonspecific binding was subtracted from the total binding in all cases.
Results
The binding of [ (1 ,uM) .
As may be seen in the binding isotherm (Figure 1 ), there is a high level of nonspecific binding. However, as shown by the autoradiographs, nonspecific binding is attributable mainly to cardiac myocytes and associated interstitial stroma, which are compartments that have a low level of specific binding sites and account for the great bulk of the nonspecific binding seen in the isotherm. Thus, when studying sections of vessel, which contain the major concentration of specific binding sites, at a CGRP concentration of 250 pM, specific binding represented more than 50% of total binding in all sections studied.
High concentrations of CGRP were bound to coronary arteries (Figures 2 and 3) , veins, and the cardiac valves (Figure 4) . Arterioles, great vessels, and endocardium showed a lesser degree of specific binding. The large coronary arteries were more densely labeled than small arteries ( Figure 5 ), arterioles, and the great arteries. Myocardium, fibrous tissue, nerves, fat, and adventitia were not labeled. The results are expressed as autoradiographic grains/ 1,000 gm2 tissue and are shown in Tables 1 and 2 (mean±SEM in all cases).
The high concentration of binding sites on the valves in guinea pig heart is localized to the endocardium rather than to the fibrous tissue. Labeling of the valve in the human heart was less dense but was again present in the endocardium rather than in the fibrous stroma. Autoradiograph showing labeling in all vessels.
In three patients with ischemic heart disease, we were able to compare normal and atheromatous sections of coronary artery. We studied 11 either the same or different arteries ( Figure 6 ). Detailed counts from the patients with diseased arteries are shown in Table 3 . Occluded vessels containing thrombus had few specific binding sites over the smooth muscle. Atheroma itself takes up the ligand to a certain extent, presumably because of the endothelial proliferation that is a hallmark of the atheromatous process. Detailed evaluation of a complex lesion is shown in Figure 7 . The normal left anterior descending coronary artery and diagonal arteries contain significantly more binding sites for CGRP than did the diseased areas. Discussion We studied the distribution of CGRP receptors in human and guinea pig cardiac tissue. Cardiac vessels contain a high concentration of specific receptors for CGRP, which is consistent with a possible role for CGRP in the control of coronary vasomotor tone. A lower concentration of CGRP receptors was found in the endocardium and in the great vessels. No specific labeling was seen in the myocardium, nerve, or connective tissue.
Unlike receptor analysis on membrane preparations by radioligand binding, autoradiography allows assessment of the distribution of specific receptors.11 It is particularly useful for comparing receptor density between large, medium-sized, and small vessels, which is impossible with a membrane preparation.
The physiologic function of CGRP remains unclear. It is an extremely potent vasodilator in systemic and coronary arteries when infused at concentrations comparable to that found in the circulation.4,7 CGRP-containing nerves are found in close proximity to major coronary arteries, and CGRP is thought to act mainly by local rather than systemic release. The contribution of CGRP to regulation of coronary vasomotor tone in normal and diseased hearts remains to be established.
We have been unable to demonstrate specific receptors in myocardium and suggest that the receptors demonstrated previously in membrane homoge- Autoradiograph showing labeling in the smooth muscle of the vessel and also the atheroma. The density of labeling in the smooth muscle is less than that in the normal artery (taken from patient 2, Table 3 stain, that this binding is confined to the endothelium overlying the valve rather than to the underlying fibrous tissue. A possible explanation for the presence of these receptors may be that the endocardium and blood vessels have the same embryologic origin,12 in contrast to the myocardium.
Of interest, specific receptors are found in the endocardium. Whether the vasodilatation induced by CGRP is dependent on an intact endothelium remains controversial.13 It is clear, though, that there are both species differences and vessel differences within one species. Recent reports have stated that although the endothelium is not necessary for the relaxation of human pulmonary artery sections14 or for bovine coronary artery,15 it is necessary for the actions of CGRP on human coronary arteries. 16 Atheromatous sections of artery have a decreased number of specific binding sites for CGRP when compared with normal sections of the same artery and also distant arteries. It is not clear whether this reflects a decrease of CGRP binding sites per cell or a decrease in cellularity. CGRP is an extremely potent vasodilator, and this decrease in binding sites raises the possibility that sections of artery with a decreased density of CGRP receptors will be more prone to coronary spasm. Spasm of coronary arteries may occur in association with atheromatous disease,17 in isolation, or with so-called variant or Prinzmetal's angina.7 It is unlikely that the cause of the spasm in patients with Prinzmetal's angina is the same as that in patients with atheromatous disease. Coronary artery spasm occurring in association with atheromatous disease has been shown to occur at the site of the lesion.19 Therefore, we postulate that the decrease in receptors for CGRP found at the site of atheromatous disease will predispose that segment of artery to develop spasm. Infusion of CGRP into the coronary arteries of patients with Prinzmetal's angina had no effect on episodes of spasm,7 but the natural history of that condition is likely to be different. Because the major effects of CGRP are thought to be by local release from nerves, it is by no means certain that adequate concentrations will be reached by infusion down the vessel. 
